Nexalin Technology (NXL) Interest Coverage Ratio (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Interest Coverage Ratio of 81.53 for Q1 2026, up 43.24% year-over-year from 56.92 in Q1 2025, and down 197.6% quarter-over-quarter from 27.4 in Q4 2025.
Nexalin Technology (NXL) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Nexalin Technology's Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 81.53 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 43.24% year-over-year to 81.53; the TTM figure through Mar 2026 stood at 56.24 (down 101.74% YoY), while the FY2025 annual figure was 99.89, down 6831.2% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 81.53, down from 27.4 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 65.06 in Q4 2024, with the low at 179.18 in Q3 2024.
- The 5-year median for Interest Coverage Ratio is 81.53 (2026), against an average of 75.83.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio plunged 537.86% in 2023, then jumped 237.44% in 2024.
- Nexalin Technology's Interest Coverage Ratio stood at 18.45 in 2022, then sank by 156.56% to 47.34 in 2023, then jumped by 237.44% to 65.06 in 2024, then slumped by 142.11% to 27.4 in 2025, then sank by 197.6% to 81.53 in 2026.
- Business Quant data shows NXL's Interest Coverage Ratio at 81.53 in Q1 2026, 27.4 in Q4 2025, and 101.98 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 4.82 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 11.77 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 10.64 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 12.27 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 6.48 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -8.96 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 18.09 |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | 17,421.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.03 |
| Mar 31, 2026 | -81.53 |
| Dec 31, 2025 | -27.40 |
| Sep 30, 2025 | -101.98 |
| Jun 30, 2025 | -115.36 |
| Mar 31, 2025 | -143.66 |
| Dec 31, 2024 | 65.06 |
| Sep 30, 2024 | -179.18 |
| Jun 30, 2024 | -96.08 |
| Mar 31, 2024 | -79.53 |
| Dec 31, 2023 | -47.34 |
| Sep 30, 2023 | -178.93 |
| Jun 30, 2023 | -64.95 |
| Mar 31, 2023 | -82.04 |
| Dec 31, 2022 | -18.45 |
| Sep 30, 2022 | -28.05 |
| Jun 30, 2022 | -89.02 |
| Mar 31, 2022 | -20.69 |
| Dec 31, 2021 | -31.32 |
| Sep 30, 2021 | -66.07 |